Endoscopic ultrasonography findings in patients with non-specific changes of the pancreas on computed tomography: A single-center experience

Shailender Singh, Savio Reddymasu, Sana Waheed, Melissa Vail, Jianghua He, Jyotsna Talapaneni, Mojtaba Olyaee

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Inconclusive findings on abdominal computerized tomography (CT) scans such as "enlarged or prominent pancreas" are commonly reported; however, their clinical significance is not clearly understood. The objective was to evaluate the efficacy of endoscopic ultrasound (EUS) in a cohort of patients with indeterminate findings on CT. We undertook a retrospective, single-center study at a tertiary care university hospital. About 107 consecutive patients (56 men) underwent EUS evaluation for inconclusive CT findings. The main intervention was EUS with fine needle aspiration (FNA) The main outcome measurement was to describe lesions identified by EUS in this cohort of patients. About 22 patients (21%) had pancreatic adenocarcinoma, 14 (13%) had chronic pancreatitis, 28 (26%) had benign lesions, and 35 patients (33%) had a normal EUS exam. Pancreatic cancer was more likely to be found on EUS in patients with significant weight loss (OR 10.1; 95% CI: 3.3-30.60), hyperbilirubinemia (OR 9; 95% CI: 3-26.0), or common bile duct (CBD) dilatation (OR 3.2; 95% CI: 1.25-8.5). The limitations of the study were that we were unable to control the uniformity of CT interpretation because the scans were reviewed by multiple radiologists. There were also limited follow-up data on patients who had benign lesions or normal EUS. In conclusion, EUS is an effective modality for evaluating pancreatic lesions in patients with inconclusive findings on abdominal CT. This assists in the prompt diagnosis and institution of appropriate treatment strategies for a variety of pancreatic diseases including cancer. In the setting of inconclusive CT findings, patients with hyperbilirubinemia, significant weight loss, or CBD dilatation should undergo EUS evaluation as they are at a higher risk of having underlying pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)2799-2804
Number of pages6
JournalDigestive Diseases and Sciences
Volume53
Issue number10
DOIs
StatePublished - Oct 1 2008

Fingerprint

Endosonography
Pancreas
Tomography
Hyperbilirubinemia
Common Bile Duct
Pancreatic Neoplasms
Weight Loss
Dilatation
Pancreatic Diseases
Chronic Pancreatitis
Tertiary Healthcare
Fine Needle Biopsy
Adenocarcinoma

Keywords

  • Computerized tomography
  • Endoscopic ultrasound
  • Enlarged pancreas
  • Pancreatic cancer

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Cite this

Endoscopic ultrasonography findings in patients with non-specific changes of the pancreas on computed tomography : A single-center experience. / Singh, Shailender; Reddymasu, Savio; Waheed, Sana; Vail, Melissa; He, Jianghua; Talapaneni, Jyotsna; Olyaee, Mojtaba.

In: Digestive Diseases and Sciences, Vol. 53, No. 10, 01.10.2008, p. 2799-2804.

Research output: Contribution to journalArticle

Singh, Shailender ; Reddymasu, Savio ; Waheed, Sana ; Vail, Melissa ; He, Jianghua ; Talapaneni, Jyotsna ; Olyaee, Mojtaba. / Endoscopic ultrasonography findings in patients with non-specific changes of the pancreas on computed tomography : A single-center experience. In: Digestive Diseases and Sciences. 2008 ; Vol. 53, No. 10. pp. 2799-2804.
@article{101211c9f3c54329ba8caef712c13354,
title = "Endoscopic ultrasonography findings in patients with non-specific changes of the pancreas on computed tomography: A single-center experience",
abstract = "Inconclusive findings on abdominal computerized tomography (CT) scans such as {"}enlarged or prominent pancreas{"} are commonly reported; however, their clinical significance is not clearly understood. The objective was to evaluate the efficacy of endoscopic ultrasound (EUS) in a cohort of patients with indeterminate findings on CT. We undertook a retrospective, single-center study at a tertiary care university hospital. About 107 consecutive patients (56 men) underwent EUS evaluation for inconclusive CT findings. The main intervention was EUS with fine needle aspiration (FNA) The main outcome measurement was to describe lesions identified by EUS in this cohort of patients. About 22 patients (21{\%}) had pancreatic adenocarcinoma, 14 (13{\%}) had chronic pancreatitis, 28 (26{\%}) had benign lesions, and 35 patients (33{\%}) had a normal EUS exam. Pancreatic cancer was more likely to be found on EUS in patients with significant weight loss (OR 10.1; 95{\%} CI: 3.3-30.60), hyperbilirubinemia (OR 9; 95{\%} CI: 3-26.0), or common bile duct (CBD) dilatation (OR 3.2; 95{\%} CI: 1.25-8.5). The limitations of the study were that we were unable to control the uniformity of CT interpretation because the scans were reviewed by multiple radiologists. There were also limited follow-up data on patients who had benign lesions or normal EUS. In conclusion, EUS is an effective modality for evaluating pancreatic lesions in patients with inconclusive findings on abdominal CT. This assists in the prompt diagnosis and institution of appropriate treatment strategies for a variety of pancreatic diseases including cancer. In the setting of inconclusive CT findings, patients with hyperbilirubinemia, significant weight loss, or CBD dilatation should undergo EUS evaluation as they are at a higher risk of having underlying pancreatic cancer.",
keywords = "Computerized tomography, Endoscopic ultrasound, Enlarged pancreas, Pancreatic cancer",
author = "Shailender Singh and Savio Reddymasu and Sana Waheed and Melissa Vail and Jianghua He and Jyotsna Talapaneni and Mojtaba Olyaee",
year = "2008",
month = "10",
day = "1",
doi = "10.1007/s10620-008-0204-3",
language = "English (US)",
volume = "53",
pages = "2799--2804",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "10",

}

TY - JOUR

T1 - Endoscopic ultrasonography findings in patients with non-specific changes of the pancreas on computed tomography

T2 - A single-center experience

AU - Singh, Shailender

AU - Reddymasu, Savio

AU - Waheed, Sana

AU - Vail, Melissa

AU - He, Jianghua

AU - Talapaneni, Jyotsna

AU - Olyaee, Mojtaba

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Inconclusive findings on abdominal computerized tomography (CT) scans such as "enlarged or prominent pancreas" are commonly reported; however, their clinical significance is not clearly understood. The objective was to evaluate the efficacy of endoscopic ultrasound (EUS) in a cohort of patients with indeterminate findings on CT. We undertook a retrospective, single-center study at a tertiary care university hospital. About 107 consecutive patients (56 men) underwent EUS evaluation for inconclusive CT findings. The main intervention was EUS with fine needle aspiration (FNA) The main outcome measurement was to describe lesions identified by EUS in this cohort of patients. About 22 patients (21%) had pancreatic adenocarcinoma, 14 (13%) had chronic pancreatitis, 28 (26%) had benign lesions, and 35 patients (33%) had a normal EUS exam. Pancreatic cancer was more likely to be found on EUS in patients with significant weight loss (OR 10.1; 95% CI: 3.3-30.60), hyperbilirubinemia (OR 9; 95% CI: 3-26.0), or common bile duct (CBD) dilatation (OR 3.2; 95% CI: 1.25-8.5). The limitations of the study were that we were unable to control the uniformity of CT interpretation because the scans were reviewed by multiple radiologists. There were also limited follow-up data on patients who had benign lesions or normal EUS. In conclusion, EUS is an effective modality for evaluating pancreatic lesions in patients with inconclusive findings on abdominal CT. This assists in the prompt diagnosis and institution of appropriate treatment strategies for a variety of pancreatic diseases including cancer. In the setting of inconclusive CT findings, patients with hyperbilirubinemia, significant weight loss, or CBD dilatation should undergo EUS evaluation as they are at a higher risk of having underlying pancreatic cancer.

AB - Inconclusive findings on abdominal computerized tomography (CT) scans such as "enlarged or prominent pancreas" are commonly reported; however, their clinical significance is not clearly understood. The objective was to evaluate the efficacy of endoscopic ultrasound (EUS) in a cohort of patients with indeterminate findings on CT. We undertook a retrospective, single-center study at a tertiary care university hospital. About 107 consecutive patients (56 men) underwent EUS evaluation for inconclusive CT findings. The main intervention was EUS with fine needle aspiration (FNA) The main outcome measurement was to describe lesions identified by EUS in this cohort of patients. About 22 patients (21%) had pancreatic adenocarcinoma, 14 (13%) had chronic pancreatitis, 28 (26%) had benign lesions, and 35 patients (33%) had a normal EUS exam. Pancreatic cancer was more likely to be found on EUS in patients with significant weight loss (OR 10.1; 95% CI: 3.3-30.60), hyperbilirubinemia (OR 9; 95% CI: 3-26.0), or common bile duct (CBD) dilatation (OR 3.2; 95% CI: 1.25-8.5). The limitations of the study were that we were unable to control the uniformity of CT interpretation because the scans were reviewed by multiple radiologists. There were also limited follow-up data on patients who had benign lesions or normal EUS. In conclusion, EUS is an effective modality for evaluating pancreatic lesions in patients with inconclusive findings on abdominal CT. This assists in the prompt diagnosis and institution of appropriate treatment strategies for a variety of pancreatic diseases including cancer. In the setting of inconclusive CT findings, patients with hyperbilirubinemia, significant weight loss, or CBD dilatation should undergo EUS evaluation as they are at a higher risk of having underlying pancreatic cancer.

KW - Computerized tomography

KW - Endoscopic ultrasound

KW - Enlarged pancreas

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=50949085613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50949085613&partnerID=8YFLogxK

U2 - 10.1007/s10620-008-0204-3

DO - 10.1007/s10620-008-0204-3

M3 - Article

C2 - 18320316

AN - SCOPUS:50949085613

VL - 53

SP - 2799

EP - 2804

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 10

ER -